ITRM20030363A0 - Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. - Google Patents

Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.

Info

Publication number
ITRM20030363A0
ITRM20030363A0 IT2003RM000363A ITRM20030363A ITRM20030363A0 IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0 IT 2003RM000363 A IT2003RM000363 A IT 2003RM000363A IT RM20030363 A ITRM20030363 A IT RM20030363A IT RM20030363 A0 ITRM20030363 A0 IT RM20030363A0
Authority
IT
Italy
Prior art keywords
diesse
compositions including
pharmaceutical use
pharmaceutical
compositions
Prior art date
Application number
IT2003RM000363A
Other languages
English (en)
Inventor
Fernando Goglia
Antonia Lanni
Maria Moreno
Assunta Lombardi
Original Assignee
Fernando Goglia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fernando Goglia filed Critical Fernando Goglia
Priority to IT000363A priority Critical patent/ITRM20030363A1/it
Publication of ITRM20030363A0 publication Critical patent/ITRM20030363A0/it
Priority to PCT/IT2004/000402 priority patent/WO2005009433A1/en
Publication of ITRM20030363A1 publication Critical patent/ITRM20030363A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000363A 2003-07-24 2003-07-24 Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. ITRM20030363A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (it) 2003-07-24 2003-07-24 Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
PCT/IT2004/000402 WO2005009433A1 (en) 2003-07-24 2004-07-22 Use of 3,5 diiodothyronine as regulators of lipid metabolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000363A ITRM20030363A1 (it) 2003-07-24 2003-07-24 Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.

Publications (2)

Publication Number Publication Date
ITRM20030363A0 true ITRM20030363A0 (it) 2003-07-24
ITRM20030363A1 ITRM20030363A1 (it) 2005-01-25

Family

ID=29765933

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000363A ITRM20030363A1 (it) 2003-07-24 2003-07-24 Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.

Country Status (2)

Country Link
IT (1) ITRM20030363A1 (it)
WO (1) WO2005009433A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7504435B2 (en) 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
EP2428516A1 (en) 2003-11-19 2012-03-14 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US20090232879A1 (en) 2005-05-26 2009-09-17 Metabasis Therapeutics, Inc. Thyromimetics for the Treatment of Fatty Liver Diseases
AU2008219585A1 (en) 2007-02-27 2008-09-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
EP1992341A1 (en) * 2007-05-16 2008-11-19 Université Joseph Fourier New pharmaceutical compositions comprising a thyroid hormon and their therapeutic use
EP2068858A1 (en) * 2007-05-16 2009-06-17 Université Joseph Fourier New pharmaceutical compositions comprising diiodothyronine and their therapeutic use
ES2351274T3 (es) * 2007-06-06 2011-02-02 Torrent Pharmaceuticals Ltd Nuevos compuestos.
US20120065267A1 (en) * 2010-09-09 2012-03-15 T*Amine, Llc Compositions including 3,5-l-t2 and methods of use thereof
WO2013006402A1 (en) * 2011-07-01 2013-01-10 Thomas Najarian Methods and compositions for facilitating weight loss by administration of thyroid hormones
ES2795450T3 (es) 2012-09-17 2020-11-23 Madrigal Pharmaceuticals Inc Procedimiento para sintetizar análogos de hormonas tiroideas y polimorfos de los mismos
MX394463B (es) 2016-10-18 2025-03-19 Madrigal Pharmaceuticals Inc Métodos para tratar trastornos del hígado o trastornos lipídicos con un agonista de thr-beta.
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EA202091979A1 (ru) 2018-03-22 2021-06-22 Вайкинг Терапьютикс, Инк. Кристаллические формы и способы получения кристаллических форм соединения
EP4775207A2 (en) 2018-12-05 2026-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
EP4161925A4 (en) 2020-06-09 2024-09-04 Viking Therapeutics, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2950315A (en) * 1956-06-18 1960-08-23 Baxter Laboratories Inc Production of 3, 5-diiodothyronine
FR2197577A1 (en) * 1972-08-30 1974-03-29 Ind Chimi Ue Sa Hypocholesterolaemic, antiatheroma agents - 3,5-diiodo-4-(3-iodo-4-alkoxy-carbonyl phenoxy) phenylalkanoic acids, esters and salts
FR2501505A1 (fr) * 1981-03-11 1982-09-17 Ana Laboratoires Nouveaux medicaments destines au traitement des hyperlipidemies et hypercholesterolemies a base d'acide 3,5-diiodo-3'-isopropyl-thyroacetique
DE4026600A1 (de) * 1990-08-23 1992-02-27 Henning Berlin Gmbh Mittel zur tsh-suppression und behandlung von struma
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
WO2003094845A2 (en) * 2002-05-08 2003-11-20 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands

Also Published As

Publication number Publication date
WO2005009433A1 (en) 2005-02-03
ITRM20030363A1 (it) 2005-01-25

Similar Documents

Publication Publication Date Title
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
ITTO20010005A0 (it) Formulazione farmaceutica.
ITTO20000779A0 (it) Composizioni farmaceutiche.
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
BRPI0407755B1 (pt) composiÇço catalÍtica, sua preparaÇço e uso
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
RS20120139A3 (en) 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
IL174479A (en) The derivatives of myastrin, pharmaceutical preparations containing them and their uses
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
BR0208566B1 (pt) Derivados de Beta-Carbolina, Seu Uso, e composição Farmacêutica
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
IT1318401B1 (it) Derivati di n-desacetiltiocolchicina e composizioni farmaceutiche cheli contengono.
EP1682088A4 (en) ORAL MICROEMULSION COMPOSITION WITH BIPHENYLDIMETHYLDICARBOXYLATE AND SILYBIN
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
SV2004001441A (es) Compuestos de isocromano ref. x-14205
PT1358159E (pt) Tartrato e fosfato de 3,4 diaminopiridina, as suas composições farmacêuticas e as suas utilizações